 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
BIO TO CONCENTRATE ITS EFFORTS ON HUMAN HEALTH, AG GROUP TO FIND ANOTHER ORGANIZATION
May 29, 2025
Source: Biotechnology Innovation Organization news release
Washington, DC - The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work of its Agriculture and Environment (A&E) section to other organizations. This change is intended to enable an enhanced strategic focus on each of these respective areas of biotechnology and will be effective July 1, 2025.
"The field of biotechnology is increasingly diverse, with great threats and significant opportunities," said John F. Crowley, President and CEO, BIO. "In consultation with the BIO Executive Committee and the Agriculture and Environment Governing Board, BIO has determined that these organizational changes will enable greater focus and impact on behalf of our healthcare members, and will sharpen our advocacy work on critical policy priorities for the improvement of human health - modernizing the FDA's regulatory processes; building back a robust biopharmaceutical manufacturing base across the US and our allies; preserving strong IP protections; fostering capital formation; protecting our national security; and enabling 21st Century access to medicines.
At the same time, this change will enable A&E member companies to enhance their focus on agricultural and environmental biotech at expert third-party organizations."
"BIO has a unique position and obligation to work with policymakers, lawmakers, patients and our innovators in healthcare to modernize our clinical and regulatory systems. We must rebuild trust in our institutions and match the speed of science to advance newer and better medicines, therapies and vaccines that improve the lives of patients and their families," said Crowley.
"Moreover, the heart and soul of biotech are our emerging companies. A new center of excellence here at BIO, led by Brad, will be the foundation of greater support and continued high priority focus for these companies. I am thrilled to welcome Annetta and Brad to the BIO team, and to continue to deepen the expertise and experience we can offer to our members and the 'virtuous circle' of scientific and medical innovation."
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
|
|
|
|
|
